The first cases of as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been reported in Wuhan, China in December 2019. The World Health Organization declared the global pandemic in March 2020. Coronavirus disease 2019 (COVID-19) showed high rates of mortality in the adult popula-tion, whereas a mild course was observed in childhood. Allergic diseases, characterized by a type-2 polariza-tion of the immune system, were considered one of the major risk factor of severe COVID-19. Large amounts of clinical data and expert opinions have been collected since the pandemic outbreak. This review summarizes the latest insights on COVID-19 and allergy. (www.actabiomedica.it).
Allergy and covid-19 / De Filippo, M.; Votto, M.; Brambilla, I.; Castagnoli, R.; Montagna, L.; Caffarelli, C.; Cardinale, F.; Del Giudice, M. M.; Tosca, M.; Caimmi, S.; Licari, A.; Marseglia, G. L.. - In: ACTA BIO-MEDICA DE L'ATENEO PARMENSE. - ISSN 0392-4203. - 92:S7(2021), p. e2021522.e2021522. [10.23750/ABM.V92IS7.12402]
Allergy and covid-19
Caffarelli C.;
2021-01-01
Abstract
The first cases of as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been reported in Wuhan, China in December 2019. The World Health Organization declared the global pandemic in March 2020. Coronavirus disease 2019 (COVID-19) showed high rates of mortality in the adult popula-tion, whereas a mild course was observed in childhood. Allergic diseases, characterized by a type-2 polariza-tion of the immune system, were considered one of the major risk factor of severe COVID-19. Large amounts of clinical data and expert opinions have been collected since the pandemic outbreak. This review summarizes the latest insights on COVID-19 and allergy. (www.actabiomedica.it).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
